BioAdaptives, Inc. (BDPT) stock
BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00−0.00 (-5.56%)
Close on Oct 19, 2026Market cap $478.03KP/E –Yield –
BioAdaptives profit margin
Profit margin (net margin) is net income as a percentage of revenue.
BioAdaptives's profit margin for the twelve months ending Jun 30, 2026 was -4553.2%. For fiscal 2025 it was -8523.4%, against -7097.3% the year before. The highest annual figure on record is -2405.1% in fiscal 2019.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -8523.4% | −1426.0 |
| FY2024 | Dec 31, 2024 | -7097.3% | −4603.1 |
| FY2023 | Dec 31, 2023 | -2494.2% | +2719.9 |
| FY2022 | Dec 31, 2022 | -5214.1% | +95.1 |
| FY2021 | Dec 31, 2021 | -5309.2% | −120.0 |
| FY2020 | Dec 31, 2020 | -5189.2% | −2784.1 |
| FY2019 | Dec 31, 2019 | -2405.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 3009.0% | +7914.7 |
| Q1 FY2026 | Mar 31, 2026 | -2014.6% | +25099.0 |
| Q4 FY2025 | Dec 31, 2025 | -7896.3% | −5339.1 |
| Q3 FY2025 | Sep 30, 2025 | -8193.0% | −4467.2 |
| Q2 FY2025 | Jun 30, 2025 | -4905.7% | −4822.2 |
| Q2 FY2024 | Jun 30, 2024 | -27113.6% | −20960.7 |
| Q1 FY2024 | Mar 31, 2024 | -2557.2% | +5949.6 |
| Q4 FY2023 | Dec 31, 2023 | -3725.9% | −3016.1 |
| Q3 FY2023 | Sep 30, 2023 | -83.5% | +8197.2 |
| Q2 FY2023 | Jun 30, 2023 | -6152.9% | −973.9 |
| Q1 FY2023 | Mar 31, 2023 | -8506.7% | −1871.4 |
| Q4 FY2022 | Dec 31, 2022 | -709.8% | +4854.6 |
| Q3 FY2022 | Sep 30, 2022 | -8280.6% | −7634.5 |
| Q2 FY2022 | Jun 30, 2022 | -5179.0% | −80.2 |
| Q1 FY2022 | Mar 31, 2022 | -6635.3% | +4252.3 |
| Q4 FY2021 | Dec 31, 2021 | -5564.3% | −1130.6 |
| Q3 FY2021 | Sep 30, 2021 | -646.1% | −342.8 |
| Q2 FY2021 | Jun 30, 2021 | -5098.9% | +7192.3 |
| Q1 FY2021 | Mar 31, 2021 | -10887.6% | −5776.5 |
| Q4 FY2020 | Dec 31, 2020 | -4433.8% | +3929.5 |
| Q3 FY2020 | Sep 30, 2020 | -303.3% | +2341.5 |
| Q2 FY2020 | Jun 30, 2020 | -12291.1% | −8812.7 |
| Q1 FY2020 | Mar 31, 2020 | -5111.1% | −11145.4 |
| Q4 FY2019 | Dec 31, 2019 | -8363.3% | −8143.0 |
| Q3 FY2019 | Sep 30, 2019 | -2644.7% | – |
| Q2 FY2019 | Jun 30, 2019 | -3478.5% | – |
| Q1 FY2019 | Mar 31, 2019 | 6034.3% | – |
| Q3 FY2016 | Sep 30, 2016 | -220.3% | – |
See a number that looks wrong?